glp-1 agonist therapy information platforms Medications Infographic GLP-1 Receptor Agonist Market Size

New insights into beta-cell GLP-1 receptor and cAMP signaling

Prominent players in the GLP-1 agonists market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France) To view or add a comment, sign in - & : The global race in GLP-1 therapeutics is intensifying, with industry leaders like Novo Nordisk A/S and Eli Lilly and Company at the forefront of innovation

It's involved in regulating your appetite, blood sugar, and digestion

For instance, exendin-4 has been shown to ameliorate the high glucose-induced fibronectin (FN) and type I collagen (Col1) expression in tubular epithelial cells by inhibiting the secretion of miR-192, an microRNA (miRNA) that is regulated by p53 and plays a role in renal fibrosis (Li et al., 2018)

Cision PR Newswire